News

03 August 2026
Meet the Summer Scholar Uncovering How Bacteria Communicate
Jimuel Clarence Malimban is gaining hands-on research experience using genetic tools to better understand bacterial behavior
Read Article
News
American Century Investments CEO, Jonathan Thomas, recently spoke with 401k Specialist Magazine. He highlighted how the world-class research happening at the Stowers Institute is made possible.

In the article, Thomas explained the Stowers Institute was started by Jim and Virginia Stowers. Their experiences and medical backgrounds fueled a passion for helping others, and in 1994 the Institute was born.
“It’s an amazing story, and I can’t believe it isn’t more well known,” Thomas told 401kSpecialist.
“They traveled the world trying to figure out what to do,” Thomas explained. “They realized a lot of the therapies and cures back then hadn’t evolved over time. They decided to do something that almost nobody does while they’re alive; they gave away almost every penny of their wealth from American Century Investments, including stock ownership, to medical research. Today, the institute is our largest single owner.”
“It’s real money,” Thomas added. “It has between 500 and 600 staff people and 17 separate principal investigators. They’re all focused on finding cures for gene-based diseases—diabetes, cancer, osteoporosis, memory issues, etc.—and things like regeneration. It’s fascinating, and this great work is all funded by American Century.”
The article explains the partnership gives American Century employees an incredible sense of purpose knowing they are helping advance medical breakthroughs for generations. “It’s the most inspiring thing you can imagine,” Thomas said.
Read the full article here.
News

03 August 2026
Jimuel Clarence Malimban is gaining hands-on research experience using genetic tools to better understand bacterial behavior
Read Article
Press Release

30 July 2026
Charles McAnany, Ph.D., uses machine learning to help decode how DNA controls gene activity and reveal hidden patterns in the genome. He will now enhance AI accessibility and implementation across the Institute’s 24 research programs.
Read Article
News
30 July 2026
Promoted to Investigator, Randal Halfmann, Ph.D., has built a research program around the molecular events that help cells adapt, defend themselves, and sometimes begin a path toward disease — and there are plenty of questions he still wants to ask.
Read Article